Literature DB >> 31699793

Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma.

Seiichiro Katagiri1, Hideki Makishima2, Kenko Azuma3,4, Yasuhito Nannya2, Yuu Saitoh1, Seiichiro Yoshizawa1, Daigo Akahane1, Hiroaki Fujimoto1, Yoshikazu Ito1, Ravi Velaga2, Tomohiro Umezu1,5, Junko H Ohyashiki5, Seishi Ogawa2,6,7, Kazuma Ohyashiki1,5.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31699793      PMCID: PMC7327658          DOI: 10.3324/haematol.2019.229856

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT.

Authors:  Gerbrig Berger; Leonie I Kroeze; Theresia N Koorenhof-Scheele; Aniek O de Graaf; Kenichi Yoshida; Hiroo Ueno; Yuichi Shiraishi; Satoru Miyano; Eva van den Berg; Hein Schepers; Bert A van der Reijden; Seishi Ogawa; Edo Vellenga; Joop H Jansen
Journal:  Blood       Date:  2018-01-08       Impact factor: 22.113

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

3.  Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.

Authors:  Nancy K Gillis; Markus Ball; Qing Zhang; Zhenjun Ma; YuLong Zhao; Sean J Yoder; Maria E Balasis; Tania E Mesa; David A Sallman; Jeffrey E Lancet; Rami S Komrokji; Alan F List; Howard L McLeod; Melissa Alsina; Rachid Baz; Kenneth H Shain; Dana E Rollison; Eric Padron
Journal:  Lancet Oncol       Date:  2016-12-04       Impact factor: 41.316

4.  The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

Authors:  Sabine Kayser; Konstanze Döhner; Jürgen Krauter; Claus-Henning Köhne; Heinz A Horst; Gerhard Held; Marie von Lilienfeld-Toal; Sibylla Wilhelm; Andrea Kündgen; Katharina Götze; Mathias Rummel; David Nachbaur; Brigitte Schlegelberger; Gudrun Göhring; Daniela Späth; Carina Morlok; Manuela Zucknick; Arnold Ganser; Hartmut Döhner; Richard F Schlenk
Journal:  Blood       Date:  2010-12-02       Impact factor: 22.113

5.  Age-related clonal hematopoiesis associated with adverse outcomes.

Authors:  Siddhartha Jaiswal; Pierre Fontanillas; Jason Flannick; Alisa Manning; Peter V Grauman; Brenton G Mar; R Coleman Lindsley; Craig H Mermel; Noel Burtt; Alejandro Chavez; John M Higgins; Vladislav Moltchanov; Frank C Kuo; Michael J Kluk; Brian Henderson; Leena Kinnunen; Heikki A Koistinen; Claes Ladenvall; Gad Getz; Adolfo Correa; Benjamin F Banahan; Stacey Gabriel; Sekar Kathiresan; Heather M Stringham; Mark I McCarthy; Michael Boehnke; Jaakko Tuomilehto; Christopher Haiman; Leif Groop; Gil Atzmon; James G Wilson; Donna Neuberg; David Altshuler; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

6.  Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

Authors:  Tetsuichi Yoshizato; Yasuhito Nannya; Yoshiko Atsuta; Yusuke Shiozawa; Yuka Iijima-Yamashita; Kenichi Yoshida; Yuichi Shiraishi; Hiromichi Suzuki; Yasunobu Nagata; Yusuke Sato; Nobuyuki Kakiuchi; Keitaro Matsuo; Makoto Onizuka; Keisuke Kataoka; Kenichi Chiba; Hiroko Tanaka; Hiroo Ueno; Masahiro M Nakagawa; Bartlomiej Przychodzen; Claudia Haferlach; Wolfgang Kern; Kosuke Aoki; Hidehiro Itonaga; Yoshinobu Kanda; Mikkael A Sekeres; Jaroslaw P Maciejewski; Torsten Haferlach; Yasushi Miyazaki; Keizo Horibe; Masashi Sanada; Satoru Miyano; Hideki Makishima; Seishi Ogawa
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

7.  Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.

Authors:  Koichi Takahashi; Feng Wang; Hagop Kantarjian; Denaha Doss; Kanhav Khanna; Erika Thompson; Li Zhao; Keyur Patel; Sattva Neelapu; Curtis Gumbs; Carlos Bueso-Ramos; Courtney D DiNardo; Simona Colla; Farhad Ravandi; Jianhua Zhang; Xuelin Huang; Xifeng Wu; Felipe Samaniego; Guillermo Garcia-Manero; P Andrew Futreal
Journal:  Lancet Oncol       Date:  2016-12-03       Impact factor: 41.316

8.  Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia.

Authors:  Yusuke Shiozawa; Luca Malcovati; Anna Gallì; Aiko Sato-Otsubo; Keisuke Kataoka; Yusuke Sato; Yosaku Watatani; Hiromichi Suzuki; Tetsuichi Yoshizato; Kenichi Yoshida; Masashi Sanada; Hideki Makishima; Yuichi Shiraishi; Kenichi Chiba; Eva Hellström-Lindberg; Satoru Miyano; Seishi Ogawa; Mario Cazzola
Journal:  Nat Commun       Date:  2018-09-07       Impact factor: 14.919

9.  Detectable clonal mosaicism from birth to old age and its relationship to cancer.

Authors:  Cathy C Laurie; Cecelia A Laurie; Kenneth Rice; Kimberly F Doheny; Leila R Zelnick; Caitlin P McHugh; Hua Ling; Kurt N Hetrick; Elizabeth W Pugh; Chris Amos; Qingyi Wei; Li-e Wang; Jeffrey E Lee; Kathleen C Barnes; Nadia N Hansel; Rasika Mathias; Denise Daley; Terri H Beaty; Alan F Scott; Ingo Ruczinski; Rob B Scharpf; Laura J Bierut; Sarah M Hartz; Maria Teresa Landi; Neal D Freedman; Lynn R Goldin; David Ginsburg; Jun Li; Karl C Desch; Sara S Strom; William J Blot; Lisa B Signorello; Sue A Ingles; Stephen J Chanock; Sonja I Berndt; Loic Le Marchand; Brian E Henderson; Kristine R Monroe; John A Heit; Mariza de Andrade; Sebastian M Armasu; Cynthia Regnier; William L Lowe; M Geoffrey Hayes; Mary L Marazita; Eleanor Feingold; Jeffrey C Murray; Mads Melbye; Bjarke Feenstra; Jae H Kang; Janey L Wiggs; Gail P Jarvik; Andrew N McDavid; Venkatraman E Seshan; Daniel B Mirel; Andrew Crenshaw; Nataliya Sharopova; Anastasia Wise; Jess Shen; David R Crosslin; David M Levine; Xiuwen Zheng; Jenna I Udren; Siiri Bennett; Sarah C Nelson; Stephanie M Gogarten; Matthew P Conomos; Patrick Heagerty; Teri Manolio; Louis R Pasquale; Christopher A Haiman; Neil Caporaso; Bruce S Weir
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

10.  Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors:  Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal:  Nature       Date:  2014-12-08       Impact factor: 49.962

View more
  1 in total

Review 1.  Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance.

Authors:  Layla Al-Mansoori; Hend Al-Jaber; Mohammad Shoaib Prince; Mohamed A Elrayess
Journal:  Inflammation       Date:  2021-09-18       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.